Search by Drug Name or NDC
NDC 24510-0232-60 Nucynta 200 mg/1 Details
Nucynta 200 mg/1
Nucynta is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Collegium Pharmaceutical, Inc.. The primary component is TAPENTADOL HYDROCHLORIDE.
MedlinePlus Drug Summary
Tapentadol tablets are used to treat moderate to severe acute pain (pain that begins suddenly, has a specific cause, and is expected to go away when the cause of the pain is healed). Tapentadol extended-release tablets are used to treat severe neuropathic pain (pain caused by nerve damage) in people who have diabetes. Tapentadol extended-release tablets are only used to treat people who are expected to need medication around-the-clock to relieve pain that cannot be controlled by the use of other pain medications. Tapentadol is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain.
Related Packages: 24510-0232-60Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Tapentadol
Product Information
| NDC | 24510-0232 |
|---|---|
| Product ID | 24510-232_550b9ed6-ebbd-4982-9b45-6bccc9b43bb4 |
| Associated GPIs | 65100091107450 |
| GCN Sequence Number | 067270 |
| GCN Sequence Number Description | tapentadol HCl TAB ER 12H 200 MG ORAL |
| HIC3 | H3A |
| HIC3 Description | OPIOID ANALGESICS |
| GCN | 29791 |
| HICL Sequence Number | 036411 |
| HICL Sequence Number Description | TAPENTADOL HCL |
| Brand/Generic | Brand |
| Proprietary Name | Nucynta |
| Proprietary Name Suffix | ER |
| Non-Proprietary Name | tapentadol hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | mg/1 |
| Substance Name | TAPENTADOL HYDROCHLORIDE |
| Labeler Name | Collegium Pharmaceutical, Inc. |
| Pharmaceutical Class | Opioid Agonist [EPC], Opioid Agonists [MoA] |
| DEA Schedule | CII |
| Marketing Category | NDA |
| Application Number | NDA200533 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 24510-0232-60 (24510023260)
| NDC Package Code | 24510-232-60 |
|---|---|
| Billing NDC | 24510023260 |
| Package | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24510-232-60) |
| Marketing Start Date | 2019-04-19 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 32.1562 |
| Pricing Unit | EA |
| Effective Date | 2024-01-01 |
| NDC Description | NUCYNTA ER 200 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |